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Aim: Early psychosis has been identified as period during which rapid identification and 
treatment can lead to significant improvement in clinical and functional outcomes. Despite 
increased research, no studies have examined early psychosis in Veteran populations. It is 
unknown whether Veterans differ from non-Veterans at this stage of the disorder, and if 
the treatments offered to non-Veterans are appropriate to implement in Veteran Affairs 
Medical Centers. Given differences that appear between Veterans and non-Veterans in 
chronic psychosis, additional work is necessary to determine the best way to approach 
specialized treatment for Veterans experiencing early psychosis. Methods: The current 
study is a secondary analysis of assessment batteries collected at a community-based early 
intervention program and at a local Veteran Affairs Medical Center. Assessment results 
were compared for Veterans’ and non-Veterans’ background characteristics, symptoms, 
and neurocognitive deficits. Results: Significant differences were found between the two 
samples on age of illness onset, marital status, education level, positive symptoms of 
psychosis, and neurocognitive functioning. Logistic regression analyses identified age of 
onset as a potential underlying factor. Conclusions: While some aspects of illness 
presentation appear similar between Veterans and non-Veterans, there are important 
differences between these populations. Pre-existing treatment interventions, such as Social 
Skills Training, cognitive remediation approaches and cognitive behavior therapy for 
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psychosis may be appropriate to implement with Veterans. Others– such as family based 
interventions or supported employment services – may need to be tailored to maximize the 
benefit for Veterans. 
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INTRODUCTION 
Early psychosis, the first few years of a psychotic disorder (e.g. schizophrenia, 
schizoaffective disorder), is a critical period that requires rapid identification and 
subsequent treatment (Breitborde, Srihari, & Woods, 2009; Cuesta et al., 2012; Perkins, 
Gu, Boteva, & Lieberman, 2005). Over the last decade, interest in early psychosis has 
increased and research has focused on understanding the presentation of the disorder in the 
general population (Bertolote & McGorry, 2005; Harris et al., 2005; McGorry, Killackey, 
& Yung, 2008). One population that has received little attention in early psychosis research 
is the Veteran population; there have been no studies examining early psychosis in 
Veterans. It is unknown whether Veterans differ from non-Veterans in their presentation 
of symptoms or whether specific services are necessary to meet the needs of Veterans 
experiencing early psychosis. However, given the differences between Veterans and non-
Veterans in access to specialized treatment services, as well as differences in illness 
presentation of Veterans and non-Veterans with chronic psychosis, additional work is 
needed to determine appropriate treatment approaches.  
Specialized programs have been developed to aid in the early identification and 
swift treatment of early psychosis (Edwards, Harris, & Bapat, 2005; Garety et al., 2006; 
Marshall & Rathbone, 2011; McGorry et al., 2008). Research suggests that specialized 
early intervention services can lead to faster symptom reduction, less intense illness 
trajectory, better illness self-management and increased social and role functioning 
(Marshall et al., 2005; R. M. Norman & Malla, 2001; Perkins et al., 2005). While many 
early intervention programs reside in academic centers, teaching hospitals or specialized 
outpatient clinics (Amminger et al., 2011; Bodén, Sundström, Lindström, Wieselgren, & 
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Lindström, 2010; Jørgensen et al., 2000; Malla, Norman, McLean, Scholten, & Townsend, 
2003), Veterans Affairs Medical Centers (VAMCs), which offer medical services to those 
eligible after discharge from the United States military, have not yet developed specialized 
intervention services for Veterans experiencing early psychosis. The existing early 
intervention programs cater to the general population, and do not provide a focus on 
Veteran care. While it is tempting to simply recommend the implementation of successful 
community based early intervention services, research cautions against planning VAMC 
health care based on non-Veteran patient populations (Agha, Lofgren, VanRuiswyk, & 
Layde, 2000). It has been noted that the Veteran and non-Veteran populations differ across 
a variety of health care needs, and basing services on a population with different needs 
could lead to poor allocation of treatment options (Agha et al., 2000; Peabody & Luck, 
1998; Wolinsky, Coe, Mosely, & Homan, 1985). Given this is a new area of exploration, 
understanding how Veterans and non-Veterans with chronic psychosis differ, may inform 
important areas to focus early psychosis research efforts. 
Within the chronic psychosis literature, evidence suggests a variety of differences 
between Veterans and non-Veterans (Firmin, Luther, Lysaker, & Salyers, 2016; Harvey et 
al., 2000; Thorp et al., 2012). The age of onset of psychosis tends to be later for Veterans 
than for non-Veterans. While the common age of onset in the general population ranges 
from 16 to 25 years (Lecomte et al., 2008; Reading & Birchwood, 2005), the average age 
of onset for Veterans is approximately 28 years (Harvey et al., 2000; Marsh et al., 1999; 
Thorp et al., 2012). In addition to age, Veterans with chronic psychosis have also been 
shown to have higher levels of education when compared to non-Veterans (Firmin et al., 
2016; Harvey et al., 2000; Marsh et al., 1999; Thorp et al., 2012). Finally, research suggests 
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that Veterans with chronic psychosis are more likely to be married, or to have previously 
been married, than non-Veterans (Firmin et al., 2016; Thorp et al., 2012). Marital status 
may be tied both to later age of onset and to higher levels of social functioning, as 
individuals with greater deficits in social skills may find intimate relationships more 
challenging. If non-Veterans are experiencing earlier ages of onset, the disruption in 
functioning may stunt the progress of age appropriate milestones (e.g. serious romantic 
relationships, completion of education, career development). In addition to background 
characteristics, there may be aspects of symptomology or functioning that differ between 
the two populations.  
Psychotic symptoms are a highly-researched aspect of psychosis, as is insight into 
illness.  Differences between Veterans and non-Veterans have been noted for chronic 
psychotic symptom severity.  Evidence suggests positive psychotic symptoms do not 
appear to differ between groups; however, Veterans with chronic psychosis tend to have 
less severe negative symptoms (Harvey et al., 2000; Thorp et al., 2012). Deficits with 
insight are prevalent in both chronic and early psychosis as well, and can impact an 
individuals’ perception of their psychotic symptoms (Lysaker, Bell, Bryson, & Kaplan, 
1998; Vohs et al., 2015). While differences between Veteran and non-Veterans have not 
been explored in terms of insight into illness, impaired insight often creates difficulties in 
an individual’s awareness of their own mental illness, and a distinct unawareness of the 
need for treatment (Ayesa-Arriola et al., 2014; R. J. Drake et al., 2007; Vohs et al., 2014; 
Vohs et al., 2015). Difficulty in these both areas can negatively impact engagement in 
treatment, and further exacerbate additional co-morbid symptoms such as depression and 
suicidality.  
4 
 
The risk for co-morbid depression is high in all stages of psychosis (D. Addington 
& Addington, 1992; Crumlish et al., 2005; Power et al., 2003); however, early psychosis 
presents a uniquely high risk state (Barrett et al., 2010; Clarke et al., 2006; Pompili et al., 
2011; Robinson et al., 2010; Romm et al., 2010; Upthegrove et al., 2010). Studies have 
found over half of individuals who experience early psychosis will experience at least one 
major depressive episode (Romm et al., 2010; Upthegrove et al., 2010). Additionally, up 
to 30% of Veterans are affected by depression, making it one of the most common chronic 
conditions experienced in VAMC populations (Cully, Zimmer, Khan, & Petersen, 2008; 
Hankin, Spiro III, Miller, & Kazis, 1999; Kaplan, Huguet, McFarland, & Newsom, 2007). 
While differences in suicidality have not been explicitly examined between Veterans and 
non-Veterans with chronic psychosis, Veteran status alone elevates an individual’s risk for 
suicide; the general population experiencing a psychiatric diagnosis has a 15% suicide risk 
factor, Veteran status elevates this risk to over 50% (Ilgen, Bohnert, Ignacio, & et al., 2010; 
Kaplan et al., 2007; Lambert et al., 2005; Zivin et al., 2007). This suggests Veterans with 
psychiatric diagnoses such as psychosis would also experience an increased risk for 
depression and suicidality. While many non-Veteran early psychosis programs incorporate 
care for co-morbid depression (White, Luther, Bonfils, & Salyers, 2015), Veteran status 
may place individuals in this group at an elevated risk. 
Functioning, both social and role, is another area of concern for individuals with 
psychosis. Deficits in functioning have been widely documented for this population (J. 
Addington & Addington, 1999; Dickerson, Boronow, Ringel, & Parente, 1999; Fett, 
Viechtbauer, Penn, van Os, & Krabbendam, 2011). Evidence suggests Veterans have better 
self-care, social functioning, recreation planning, activities of daily living and interpersonal 
5 
 
communication (Harvey et al., 2000; Thorp et al., 2012). It is unclear what drives these 
differences in functioning, and examining whether these differences are present early in 
the development of a psychotic disorder could allow for better capitalization on any 
protective factors that may exist (Firmin et al., 2016).  
Few studies exist exploring neurocognitive differences between Veterans and non-
Veterans with chronic psychosis. Though some differences in verbal memory and working 
memory have been noted, results have been conflicting (Harvey et al., 2000; Thorp et al., 
2012). Given the lack of research examining neurocognitive differences between Veterans 
and non-Veterans, it is unclear whether these differences would be present in an early 
psychosis population. For example, it is possible that the conflicting results may be tied to 
a separate driving factor, such as differences in antipsychotic medication doses (Keefe, 
Seidman, et al., 2004; Keefe, Silva, Perkins, & Lieberman, 1999), age of onset, or 
education levels (R. M. Norman & Malla, 2001; Simonsen et al., 2009). 
In addition to the above-noted domains, there are other important areas that warrant 
exploration in Veteran and non-Veteran early psychosis samples, such as social anxiety. 
Social anxiety is a common problem in psychosis and, similarly to deficits in insight, can 
impact the ability of someone in early psychosis to benefit from specialized treatment 
(Ayesa-Arriola et al., 2014; Birchwood et al., 2007; R. J. Drake et al., 2007; Voges & 
Addington, 2005; Vohs et al., 2015).  For example, social anxiety has been identified as a 
co-morbid disorder in up to 30% of individuals with a psychotic diagnosis (Birchwood et 
al., 2007; Voges & Addington, 2005).  Moreover, social anxiety is associated with negative 
symptoms and poor social functioning (Blanchard, Mueser, & Bellack, 1998; Penn, Hope, 
Spaulding, & Kucera, 1994; Romm et al., 2011; Voges & Addington, 2005). Social anxiety 
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has not yet been explicitly examined in a population of Veterans with early psychosis; 
gaining a better understanding of social anxiety may help to overcome treatment 
engagement and point to the need for special interventions (Goodwin & Fitzgibbon, 2002; 
Kingsep, Nathan, & Castle, 2003).  
Current Study 
Given the dearth of information on Veterans with early psychosis and the need for 
a greater understanding of how this population may differ from the general population with 
early psychosis, the current study aimed to summarize characteristics of Veterans with 
early psychosis, and compared this sample to non-Veterans with early psychosis. Existing 
literature supports the idea of differences being prevalent between Veterans and non-
Veterans with chronic psychosis, and it is possible that these differences begin early in the 
illness trajectory. Given that the age of onset for psychosis has been shown to be later in 
Veteran samples with chronic psychosis (Firmin et al., 2016; Harvey et al., 2000; Marsh et 
al., 1999; Thorp et al., 2012), we hypothesized that our Veteran sample would have a later 
age of onset than non-Veterans, and would have a higher level of education and would be 
more likely to either be married, or have previously been married than non-Veterans. 
Evidence suggests that Veterans and non-Veterans with chronic psychosis have similar 
positive symptom severity (Harvey et al., 2000; Thorp et al., 2012), but Veterans display 
less severe negative symptoms (Marsh et al., 1999; Thorp et al., 2012). Additionally, 
Veterans in general display higher levels of suicidal ideations and are at a higher suicide 
risk. Therefore, we hypothesized that Veterans with early psychosis would have less severe 
negative symptoms, but more severe suicidal ideation, when compared to non-Veterans 
with early psychosis. Finally, given the differences noted in functioning between Veterans 
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and non-Veterans with chronic psychosis, we hypothesized that Veterans with early 
psychosis would have higher levels of social functioning and role functioning than non-
Veterans with early psychosis. We explored differences between Veterans and non-
Veterans across neurocognitive domains, co-morbid social anxiety, levels of insight and 
levels of depression. Additionally, we sought to further explain the role of age of illness 
onset, medication dosage, education and duration of untreated psychosis (DUP) in 
explaining differences that arose between Veterans and non-Veterans.  
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METHODS 
 
Participants 
The current study was a secondary analysis comparing cross-sectional data from 
two early psychosis samples, one from a local early intervention program (non-Veteran), 
and one from the local VAMC (Veteran). Both samples included data from similar 
assessment batteries. The non-Veteran sample was combined from two independent 
projects that occurred at the same early intervention program with the same inclusion 
criteria. The Veteran sample is a single dataset from a recently completed project. There 
was no overlap between the samples. Both the local early intervention program and the 
VAMC approved the use of data for secondary analyses. 
The total sample consisted of 76 individuals with early psychosis (16 Veterans, 60 non-
Veterans), who were within six years of their first diagnosis of a psychotic disorder at the 
time of assessment. The definition of early psychosis was determined based on clinic 
guidelines.  All diagnoses were confirmed using the Structured Clinical Interview for 
DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 1995), by a clinically trained 
professional, with a Master’s degree or greater, under the supervision of a licensed clinical 
psychologist. All subjects were 18 years or older. 
Measures 
Measures of the following domains were assessed for the full sample of Veteran 
and non-Veteran groups: symptoms (psychotic, insight, depression, social anxiety), social 
and role functioning. The remaining domains (suicidal ideation and neurocognitive 
functioning) were assessed with the full Veteran sample and a reduced non-Veteran sample 
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to maintain consistency of measurement, as these measures were not available for the 
complete non-Veteran sample. All clinician-rated measures were completed by a Master’s 
level clinician, receiving supervision from a licensed clinical psychologist. Demographic 
data was available for comparison including: age of illness onset, gender, education level, 
relationship status, race, and CPZ equivalents for medication dosages at the time of 
assessment.  
Symptoms 
The Positive and Negative Syndrome Scale for Schizophrenia.  
The PANSS (PANSS; Kay, Flszbein, & Opfer, 1987) is a clinician-rated scale 
comprised of 30 items, each representing a specific symptom of the disorder. Using a 7-
point scale, each item is rated on the degree to which the symptom was present during the 
interview (1=absent, 7=extreme). A total score is generated by combining the score of each 
item. Factor analyses of the measure have indicated a five-factor structure (Bell, Lysaker, 
Beam-Goulet, Milstein, & Lindenmayer, 1994; El Yazaji et al., 2002; Lancon, Auquier, 
Nayt, & Reine, 2000). The five factors are: negative symptoms, positive symptoms, 
disorganization/cognition, excited, and depression/anxiety (Bell et al., 1994; Lancon et al., 
2000). These factors have been found to remain stable in an early psychosis sample 
(Emsley, Rabinowitz, Medori, & Group, 2007; Emsley, Rabinowitz, & Torreman, 2003). 
Additionally, the depression/anxiety factor has been shown to be a comparable and reliable 
measure of depression in populations with psychosis (El Yazaji et al., 2002; Emsley, 
Oosthuizen, Joubert, & Stein, 1999; Emsley et al., 2003). The PANSS was used to measure 
positive symptoms, negative symptoms and total symptoms of psychosis. The PANSS was 
also used as a measure of depression because it was available for the full sample, and has 
10 
 
been shown to be reliable at measuring this construct in the early psychosis population 
(Emsley et al., 2003). For our sample, the internal reliability for the total scale was high 
(α=.85). The reliability for the positive (α=.77), negative (α=.73) and depression (α=.63) 
subscales were all acceptable.  
The Scale to Assess Unawareness of Illness.  
The Scale to Assess Unwareness of Illness (SUMD; Amador et al., 1994) is a semi-
structured clinical interview designed to elicit a subject’s level of insight into their 
psychiatric conditions. The measure is clinician-rated and has three subscales (awareness 
of illness, awareness of effects of treatment and awareness of consequence of illness). Each 
subscale is rated on a 5-point rating scale, with higher numbers indicating poor insight. 
This measure has demonstrated good to excellent reliability in prior studies (Lysaker et al., 
2011; Vohs et al., 2015), and in our current study, demonstrated a reliability of  α=.83. 
The Calgary Depression Scale for Schizophrenia. 
The Calgary Depression Scale for Schizophrenia (CDSS; D. Addington, 
Addington, & Maticka-Tyndale, 1993) is a clinician-rated measure of depression, 
specifically developed for use in a population with schizophrenia. Using a structured 
clinical interview, trained clinical raters provide scores ranging from 0 (“symptom is 
absent”) to 3 (“symptom is severe”). A total score is calculated by summing all nine items. 
Higher total scores indicate higher levels of depression. The CDSS has been shown to have 
strong reliability and validity across samples (D. Addington, Addington, & Atkinson, 
1996; D. Addington, Addington, Maticka-Tyndale, & Joyce, 1992), and the predictive and 
construct validity has been supported (D. Addington et al., 1996; D. Addington, Addington, 
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& Maticka-Tyndale, 1994). For the current study, the CDSS has been used as a measure of 
suicidality, as items specifically identify risk of suicidal ideation within a psychosis 
population. The overall reliability for the CDSS in our sample was high (α=.77). 
The Liebowitz Social Anxiety Scale.  
The Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987) is a self-report 
measure assessing the degree to which specific social interactions or performance 
situations are being feared or avoided by a subject. For each of the 24 items, the subject is 
asked to rate the degree to which they have feared the given situation in the past week, and 
how much they have been avoiding the given situation in the past week. Both fear and 
avoidance are rated on 3-point Likert-style scale with 0 = “not at all” and 3 = “A lot”. The 
scale is broken down into two primary subscales of social interactions (11 items) and public 
performance (13 items), both of which were used to assess social anxiety in the current 
samples. The measure has been shown to have strong reliability and validity in 
psychometric studies (Fresco et al., 2001; Heimberg et al., 1999). In the current sample, 
the reliability for the total LSAS scale was high (α=.95); the social interactions (α=.90) and 
public performance (α=.90) subscales were also high. 
Functioning  
The Social Functioning Scale.  
The Social Functioning Scale (SFS; Birchwood, Smith, Cochrane, Wetton, & 
Copestake, 1990) is a self-report measure used to assess seven areas of social and role 
functioning. The measure contains 79 items, each of which relates to one of the following 
areas: social engagement (e.g. “how often will you start conversations?”), interpersonal 
12 
 
communication (e.g. “how easy or difficult is it for you to carry on a conversation?”), 
prosocial activities (e.g. “How often to you visit friends? Go out to eat with others?”), 
competence (e.g. “How capable do you feel in your ability to take care of personal hygiene? 
Take transportation alone?”), activities of daily living (e.g. “How often do you clean up? 
How often do you prepare a cooked meal alone?”), recreational activities (e.g. “How often 
do you watch TV?”), and occupational activities (e.g. “Are you currently working?”). The 
SFS asks subjects to rate their ability to engage in specific activities or perform daily living 
tasks using a 4-point rating scale where higher scores indicate a higher level of functioning. 
Each subscale is summed, and converted from the summed raw score to a scaled score. The 
measure was validated on an outpatient schizophrenia sample (Birchwood et al., 1990; 
Dickerson et al., 1999). The reliability of the total measure in the current sample was 
(α=.69). 
The Quality of Life Scale 
The Quality of Life Scale  (QLS; Heinrichs, Hanlon, & Carpenter, 1984) is a 21-
item measure, designed specifically to assess deficits in functioning in psychosis 
populations. The semi-structured interview obtains data on functioning over the last month, 
and the items are then rated on a 7-point scale with descriptive anchors. Although anchors 
vary across the scale, the direction of rating remains the same with a 1 indicating more 
impaired functioning and a 7 indicating better functioning. The scale assesses interpersonal 
relationships (8 items; e.g., Intimate relationships with household members), instrumental 
role functioning (4 items; e.g., Extent of occupational role functioning), intrapsychic 
foundations (7 items; e.g., Capacity for empathy) and common objects/activities (2 items; 
e.g., Current possession of common objects required for daily living). The reliability and 
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validity of this measure has been tested in multiple studies and found acceptable across all 
subscales (Browne et al., 2000; Heinrichs et al., 1984; Lehman, 1996; Lehman, Postrado, 
& Rachuba, 1993). For the current study, the instrumental role functioning and common 
objects/activities subscales were used to measure role functioning in both samples. The 
reliability for the total score was high for the current sample (α=.78).  
Measurement of neurocognitive functioning 
The Brief Assessment of Cognition in Schizophrenia. 
The Brief Assessment of Cognition in Schizophrenai (BACS; Keefe, Goldberg, et 
al., 2004) is a specialized assessment battery designed to measure the aspects of cognition 
that are commonly found to be most impaired in schizophrenia spectrum populations. The 
battery is administered by a trained clinician and has been found to be highly correlated to 
longer batteries of cognition used with this population (r=.76; Keefe et al., 2004). The 
battery contains six subscales: verbal memory, working memory, motor speed, verbal 
fluency, attention and executive functions. When used in a population experiencing 
psychosis, the BACS has been shown to have high reliability and validity across the total 
score and all subscales (Keefe, Goldberg, et al., 2004). In our sample, the BACS had a high 
reliability (α=.75). Verbal memory (α=.88), working memory (α=.76) and verbal fluency 
(α=.82) also displayed high reliability in our samples. The remaining neurocognitive 
functioning domains were assessed with individual items.  
Statistical Analyses 
Data was analyzed using IMB SPSS Statistics, Version 23 (IBM, 2014). 
Descriptive statistics were calculated to describe demographic characteristics for both 
14 
 
samples (e.g. means, standard deviations). To control for demographic differences between 
Veteran and non-Veteran samples, hypotheses were tested for parametric variables using 
One-Way Analysis of Co-Variance (ANCOVA) analyses; categorical data were compared 
using Pearson’s chi-square tests. Categorical variables were dummy-coded prior to being 
entered into analyses. Following hypothesis testing, exploratory analyses including 
bivariate correlations and logistic regressions were used to better understand differences 
between the two populations. All statistical tests were two-tailed, with p-values <0.05. 
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RESULTS 
Participants 
For the full sample, participants were predominantly male (86.8%), Black (73.7%) 
and – on average – 25.2 years old at the time of assessment (see Table 1).  Amongst the 
total sample, most participants were diagnosed with schizophrenia (72.4%). The mean age 
of onset of for the full sample was 22.8 years, with an average of 318 days between onset 
of psychosis and subsequent first treatment (see Table 1). More than half of participants 
had a high school degree or less (53.9%), and 22.4%were currently, or had previously been 
married (see Table 1).  
Background Characteristics 
Overall, the three hypotheses regarding differences in background characteristics 
between Veterans and non-Veterans were supported. Veterans had a later age of onset 
(M=26.8 years, SD=4.9) than non-Veterans (M=21.4 years, SD=3.7; t(67)=-4.74, p<.001). 
Veterans were more likely to have completed education beyond high school than non-
Veterans (81.3% vs 36.7%; X2 (1,76)=10.11, p<.001). Similarly, Veterans were more likely 
to either be married, or have previously been married (56.3% vs. 13.3%; X2 (1,76)=13.40, 
p<.001). In order to explore other potential sample differences, Veterans and non-Veterans 
were compared on gender, race, diagnosis, duration of untreated psychosis, and 
chlorpromazine (CPZ) equivalent at the time of assessment. The groups did not 
significantly differ on gender (see Table 1). Non-Veterans were significantly more likely 
to be minorities (81.7% vs. 43.8%; X2 (1,76) =9.37, p=.002), and more likely to have a 
diagnosis of schizophrenia (83.3% vs. 31.3%; X2 (1,76)=17.14, p<.00). Veterans had a 
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significantly longer duration of untreated psychosis (M=749 days, SD=511.6; M=188 days, 
SD=4.7.8; t(69)=-4.32, p<.001). The Veteran sample also had a significantly lower average 
dosage of CPZ equivalent medication at the time of assessment (M=158.3, SD=215.2; 
M=357.4, SD=309.7; t(74)=2.41, p=.02).  
Symptoms 
The hypotheses regarding symptoms were not supported (see Table 2-3).  A One-
way ANCOVA was conducted to determine whether negative symptoms significantly 
differed between Veterans and non-Veterans while controlling for differences in 
demographics and medication (see Table 2). Veteran status did not have a significant effect 
on negative symptoms after controlling for demographic variables (Veteran M=21.3, 
SD=6.1; non-Veteran M=19.1, SD=6.5; F(1,69)=.74, p=.39; see Table 2). In addition, 
Veterans were not significantly more likely to report suicidal ideation when compared to 
non-Veterans: 15% Veterans vs. 12.5% non-Veterans endorsed mild to moderate suicidal 
ideations (X2 (2,36)=.56, p=.65). Contrary to expectations, Veterans had significantly more 
positive symptoms than non-Veterans, when demographic variables, including medication, 
were controlled for (Veteran M=22.4, SD=6.1; non-Veteran M=14.5, SD=5.3; 
F(1,69)=13.54, p=.001; see Table 3). When exploring differences in depression, social 
anxiety and insight into illness, no significant differences were found between Veterans 
and non-Veterans (please see Table 4-6). 
Functioning 
The hypotheses regarding social and role functioning were not supported. One-way 
ANCOVA analyses, examining Veteran status on the seven subscales of the Social 
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Functioning Scale, controlling for demographic variables, did not result in any significant 
differences between groups (see Table 7). On the QLS, One-way ANCOVA results 
indicated no significant differences between Veterans and non-Veterans on the 
instrumental role functioning subscale, nor the common objects/activities subscale when 
controlling for demographic variables (see Table 8).   
Neurocognitive Functioning 
Using One-way ANCOVAs, we explored differences in neurocognitive deficits 
between the Veteran and non-Veteran results on the BACS. Overall, Veterans had 
significantly fewer neurocognitive deficits than non-Veterans, after controlling for 
demographic variables and medication (Veterans M=35.9, SD=12.4; non-Veteran M=21.4, 
SD=14.2; F(1,36)=4.86, p=.03), based on the BACS total score. Domain-specific results 
varied (see Table 9). While Veterans and non-Veterans did not significantly differ on 
verbal memory, reasoning/problem solving or processing speed domains (see Table 9), 
working memory appears to significantly differ between the groups. On the Digit 
Sequencing task, which measures working memory, Veterans (M=44.3, SD=11.9) 
performed better than non-Veterans (M=25.8, SD=12.4) suggesting fewer deficits with 
working memory domains (F(1,36)=10.38, p=.003).  
Exploratory Analyses 
Bivariate correlations were conducted to assess the relationship between the marital 
status, education level and background characteristics (see Table 10). Logistic regression 
analyses were conducted to determine whether Veteran status was significantly related to 
marital status, and education level, controlling for age of illness onset (see Table 7-8).  
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When age of illness onset is held constant, Veteran status was no longer 
significantly related to marital status or education level (see Table 11-12).  
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DISCUSSION 
Of the seven hypotheses examined in the current study, three were supported by 
our results. As hypothesized, Veterans were significantly older at their illness onset, were 
more likely to be married, or have previously been married, and had received higher levels 
of education than non-Veterans. However, the remaining four hypotheses were not 
supported.  Veterans did not differ on negative symptoms, suicidal ideation, or social 
functioning and role functioning. Exploratory analyses of neurocognitive deficits 
highlighted potential differences between the two populations. In addition, the differences 
between Veterans and non-Veterans on positive symptoms of psychosis was the opposite 
of the expected direction - Veterans had higher levels of positive symptoms than non-
Veterans, this remained even after controlling for other demographic differences, including 
medication at the time of assessment. These results are based on a small sample of 
Veterans, and as such the results should be interpreted with caution. As a Veteran 
population, has never been examined within the context of early psychosis, these results 
may act as preliminary data to support further research with Veterans experiencing early 
psychosis, and the potential treatment implications for this population.  
Comparisons between Veterans and non-Veterans on background characteristics 
mirrored those of the chronic psychosis population (Firmin et al., 2016; Harvey et al., 2000; 
Thorp et al., 2012). Further exploratory examination suggested that the age of onset 
accounted for the relationship between Veteran-status and both marital status and 
educational level. When age of onset was entered into the prediction model, the relationship 
between Veteran status, marital status and education level was no longer significant; the 
differences that existed between the Veteran and non-Veteran groups can be attributed to 
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their respective differences in age of onset. This suggests a later age of onset is related to 
an increased likelihood to be married, and an increase in education level. It is possible that 
the age of onset acts as a driving factor for reaching age-related milestones such as marriage 
and education; an early age of onset may lead to a greater disruption in functioning, and 
could has the capacity to stunt the progress of age-related developments such as these 
(Gómez-de-Regil et al., 2010; Kessler et al., 2007). It has also been suggested that marriage 
may act as a protective factor, resulting in a later age of onset (Gureje, 1991). To better 
understand the role marriage may play as a protective factor, future studies should aim to 
identify the start of the relationship compared to the onset of psychotic symptoms.  
While knowing that the age of onset is accountable for these differences, they are 
still important factors to consider in terms of treatment planning. Veterans are more likely 
to be married, thus the inclusion of family focused services may be an important aspect of 
treatment for Veterans with early psychosis. Early intervention programs have identified 
the importance of including family as a support system (J. Addington, Amminger, et al., 
2005; J. Addington, McCleery, & Addington, 2005; Bird et al., 2010), and a number of 
interventions have been adapted to suit the early psychosis population (Fjell et al., 2007; 
Leavey et al., 2004; Zhang, Wang, Li, & Phillips, 1994).  
Offering multifamily group therapy (Asen & Schuff, 2006) or family focused 
therapy (McFarlane, Dixon, Lukens, & Lucksted, 2003) should be considered. These 
interventions typically focus on working with the individual’s parents or immediate family 
members (i.e. siblings; J. Addington, Coldham, Jones, Ko, & Addington, 2003; Onwumere, 
Bebbington, & Kuipers, 2011), and thus modifications may be necessary to tailor these 
approaches for spousal support. Offering couples therapy may also be necessary, as a 
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means of developing healthy coping mechanisms for the stress and burnout associated with 
caregivers of those with early psychosis (Boydell et al., 2014; Onwumere et al., 2011).  
Although based on a small sample, exploring how the needs to Veterans may differ 
based on their higher degree of education may allow for the implementation of effective 
education and employment interventions. Education and vocational based interventions are 
important within early psychosis treatment, and these are common services that 
participants express desire to become involved in (Bird et al., 2010; Bond, Drake, & 
Luciano, 2015; White et al., 2015). Early intervention programs typically offer Supported 
Employment and Education (Bond et al., 2015), focusing on rapid introduction back into 
the academic or workforce, with follow-up support as needed. For most early intervention 
programs, the primary focus is place on the completion of educational goals  (Bond et al., 
2015; R. E. Drake, Xie, Bond, McHugo, & Caton, 2013; Ramsay et al., 2011) . Given that 
Veterans experiencing early psychosis appear to have completed higher degrees of 
education, shifting the primary focus to career development may be warranted.  Future 
research should explore the type of services that would benefit Veterans with early 
psychosis in furthering their career aspirations. Since VAMCs currently offer vocational 
rehabilitation services (Resnick & Rosenheck, 2007), ensuring that these services are 
offered immediately to Veterans in early psychosis may help to maintain role functioning. 
Even with age of onset driving these differences in education level, accounting for them 
within treatment may help to tailor VAMC interventions for an early psychosis population 
by providing Veterans an intervention starting point that better meets their current stage of 
functioning. 
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Contrary to the pattern observed within the chronic psychosis population (Marsh et 
al., 1999; Thorp et al., 2012), negative psychotic symptoms did not significantly differ 
between the two samples. The chronic psychosis literature suggests  differences in negative 
psychotic symptoms exist (Harvey et al., 2000; Thorp et al., 2012); however, it is possible 
that these differences do not develop until later stages of the disorder. For example, non-
Veterans may experience a later worsening of negative symptoms, while Veterans with 
psychosis remain protected. With many disorders, such as schizophrenia, Post-Traumatic 
Stress Disorder (PTSD), depression and suicidality, social support, has been identified as 
a protective factor.  
Given that Veterans are more likely to be married, they may have an embedded 
social support network at home, thus increasing the likelihood of benefiting for the 
protective factors of social support. In addition, research suggests later age of onset – which 
Veterans experience – allows for the development of a greater number of social supports 
(E. M. Macdonald, Hayes, & Baglioni, 2000; R. M. G. Norman et al., 2005). The 
relationship between social support from family and friends has been positively linked to 
higher levels of both social and role functioning and better prognoses of psychotic 
symptoms (David H. Erickson, Beiser, & Iacono, 1998; David H Erickson, Beiser, Iacono, 
Fleming, & Lin, 1989; E. Macdonald, Sauer, Howie, & Albiston, 2005; E. M. Macdonald 
et al., 2000; R. M. G. Norman et al., 2005). It has been noted that although social support 
in early psychosis is linked with improved illness outcomes and functioning, the 
relationship is the most predictive after five years post-first-episode (David H. Erickson et 
al., 1998; E. M. Macdonald et al., 2000; R. M. G. Norman et al., 2005). Over time, social 
support has the capacity to bolster functioning and aid in the decrease of symptoms, which 
23 
 
may explain the later development of differences in negative symptoms between Veterans 
and non-Veterans. Examining social support provided to Veterans with early psychosis, 
could prove beneficial in identifying protective factors for negative symptoms.  
While unable to be assessed in the current study, baseline symptom severity is also 
known to predict negative symptoms severity (Haim, Rabinowitz, & Bromet, 2006; Larsen, 
Moe, Vibe-Hansen, & Johannessen, 2000). It is possible that baseline symptoms for the 
Veteran group were more severe than the non-Veteran group, or that the non-Veteran 
sample did not reflect the common level of baseline symptoms experienced by the 
remainder of the non-Veteran population. Since the non-Veteran sample was comprised of 
individuals actively seeking specialized treatment at an early intervention program it is 
possible that their level of negative symptoms is not reflective of the general population. 
Given the lack of understanding of root causes for negative symptoms, examining potential 
protective factors, as well as potential predictors may be fruitful next steps.  
Although the samples did not differ in negative symptoms, Veterans had 
significantly higher positive symptoms of psychosis than non-Veterans. This is contrary to 
the limited literature available for the chronic psychosis population that suggests Veterans 
and non-Veterans do not differ in their level of positive symptoms (Harvey et al., 2000; 
Thorp et al., 2012). Anti-psychotic medications are typically prescribed as a means of 
reducing positive symptoms (Conley & Mahmoud, 2001; Geddes, Freemantle, Harrison, 
& Bebbington, 2000). Although medication dosages significantly differed between the 
Veteran and non-Veteran samples – this difference did not fully account for the significant 
relationship between greater positive symptoms and Veteran status. While the dosage of 
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anti-psychotic medications is a contributing factor to the differences observed, it doesn’t 
fully explain the differences between the samples.  
It is possible the differences in positive symptoms were attributable to the high 
prevalence of PTSD that occurs within the Veteran population (Hamner et al., 2000). 
Research provides evidence for a high association between PTSD and positive psychotic 
symptoms – further, the literature indicates for Veterans who experiences co-morbid PTSD 
and psychotic symptoms, the degree of positive psychotic symptoms is higher than those 
experiencing PTSD or psychosis independently (Coentre & Power, 2011; Hamner, Frueh, 
Ulmer, & Arana, 1999; Hamner et al., 2000; Kilcommons & Morrison, 2005; Sareen, Cox, 
Goodwin, & J. G. Asmundson, 2005; Sautter et al., 1999). While differences in co-morbid 
PTSD could not be explored in the current study, examining how the prevalence rates of 
PTSD may differ between Veterans and non-Veterans may prove helpful in future studies.  
In addition, Veterans had a significantly longer DUP than non-Veterans, suggesting 
they experienced a greater period of active psychotic symptoms prior to receiving 
treatment. Longer DUP has been tied to more severe psychotic symptoms, and less 
improvement in future clinical outcomes (Chang et al., 2012; Cuesta et al., 2012; Marshall 
et al., 2005).  
While the current study examined a small number of Veterans and additional 
research is needed to better understand these unexpected differences, early psychosis 
research has highlighted psychosocial treatment options that target positive psychotic 
symptoms (J. Addington & Gleeson, 2005; Allott et al., 2011; Bird et al., 2010; David H 
Erickson, 2010). Cognitive Behavioral Therapy (CBT) for Psychosis has been shown to 
significantly reduce positive psychotic symptoms for individuals experiencing early 
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psychosis (J. Addington & Gleeson, 2005; Bird et al., 2010; David H Erickson, 2010). The 
VA has included CBT approaches for depression (U.S. Department of Veterans Affairs, 
2010), anxiety and chronic pain (U.S. Department of Veterans Affairs, 2008, 2012) in their 
rollout of evidence based practices, thus it may be feasible to implement an additional 
version of the protocol to specifically target Veterans with early psychosis.  
The remaining symptoms examined – depression, suicidality, social anxiety and 
insight – were not significantly different between the two samples. As this current study is 
the first to explore these symptom differences in a Veteran vs. non-Veteran capacity, the 
lack of findings is not surprising. While Veterans experience a high risk for both depression 
and suicidality (Cully et al., 2008; Hankin et al., 1999), it has been well documented that 
early psychosis in general is a highly susceptible time for these symptoms to emerge 
(Barrett et al., 2010; Clarke et al., 2006; Upthegrove et al., 2010). Given the tumultuous 
nature of the disorder at this early stage, it is likely that all individuals experiencing early 
psychosis run a high-risk of developing deficits in social anxiety and insight, and 
experiencing feelings of depression or suicidality. Additional research may be warranted 
to see if any differences develop at any later stages of psychotic disorders, or if these co-
morbid disorders are prevalent across all populations experiencing psychosis.  
Veterans did not perform better than non-Veterans on any social or role functioning 
measures. This is unexpected given the literature supporting the early development of 
social and role functioning deficits  (J. Addington, Penn, Woods, Addington, & Perkins, 
2008; Cannon et al., 1997). A number of possibilities should be considered. Given the 
protective role that social support plays in symptom severity and functioning (Brenner, 
Homaifar, Adler, Wolfman, & Kemp, 2009; R. M. G. Norman et al., 2005; Pietrzak et al., 
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2010), it is possible that social support has the capacity to impact future social functioning. 
Research suggests that social support in early psychosis is predictive of a rise in functioning 
later in the course of illness (David H. Erickson et al., 1998; E. Macdonald et al., 2005). If 
Veterans experience increased social support due to their later age of onset and tendency 
for marriage, it may be possible that social support impacts a future “rebounding” of social 
and role functioning. Veterans and non-Veterans may have similar functioning in early 
psychosis, and Veterans are able to re-gain ground in this area as their illness stabilizes. 
This future rise in functioning could account for differences observed between Veterans 
and non-Veterans with chronic psychosis. Future studies should assess the degree of social 
support provided to Veterans in early psychosis, and monitor these relationships 
longitudinally to determine the degree to which social support networks predict future 
improvements in functioning.  
In addition to social support, premorbid functioning may also be impacting social 
and role functioning our samples. Research suggests that premorbid functioning is 
predictive of chronic social functioning, as well as role functioning for individuals with 
psychosis, as these symptoms emerge prior to a full illness onset (J. Addington et al., 2008; 
Cannon et al., 1997; McClellan, Breiger, McCurry, & Hlastala, 2003). While not measured 
in the current samples, future research will need to account for premorbid functioning; if 
Veterans in our current sample were well below the average premorbid functioning in 
specific areas, it may obscure the ability to detect differences between the Veteran and non-
Veteran groups. It is also possible that the differences observed in the chronic psychosis 
literature do not develop until after a period of stabilization of psychosis – early psychosis 
is a tumultuous time, and most symptoms are typically more severe as they impact an 
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individual for the first time (Morrison, Frame, & Larkin, 2003). Additional research is 
needed to determine the specific Veteran-related factors responsible for driving these 
chronic psychosis social and role functioning differences.  
Neurocognitive deficits varied across domains tested –Veterans showed 
significantly fewer deficits overall, and on the working memory domain, while displaying 
no differences on the remaining three domains. These results mirror the limited results 
found in the chronic psychosis literature (Harvey et al., 2000; Thorp et al., 2012). More 
research is needed to explore the consistency of the differences between neurocognitive 
domains. Although less impaired, neurocognitive deficits persist for both Veterans and 
non-Veterans with early psychosis, thus implementing treatment interventions that target 
these deficits – such as cognitive remediation (Bowie, Grossman, Gupta, Oyewumi, & 
Harvey, 2014; Wykes et al., 2007) or cognitive enhancement therapy (Eack et al., 2009), – 
could benefit Veterans seeking care for early psychosis within VAMCs. 
Overall, the results of the current study suggest that while there are differences 
between Veterans and non-Veterans, there are also similarities that could allow VAMCs to 
capitalize on existing intervention approaches. While results should be interpreted with 
caution, due to the small sample sizes, focusing on rapid identification of Veterans in early 
psychosis is a strong place to start. Given there were significant differences in the DUP 
between Veterans and non-Veterans, it is evident that the identification and subsequent 
offering of treatment services is delayed for the Veteran population. It may be necessary to 
have a better understanding of when Veterans’ symptoms of early psychosis tend to emerge 
(e.g. deployment, basic training), to ensure outreach is provided during those high-risk 
times. Offering existing interventions such as CBT, Family Focused Therapy, or Supported 
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Employment services would provide a solid foundation to begin incorporating additional 
specialized interventions. Including adaptations to interventions, is likely warranted given 
that there are differences in the Veteran population -providing a focus on higher levels of 
employment or focusing on partners vs. parents in family therapy will allow for a better 
personalization of services for the Veterans. As Veterans currently have no specialized 
services offered at VAMCs for early psychosis, the inclusion of any targeted intervention 
will likely improve outcomes.  
Limitations 
There are limitations to this study that should be considered. As this was a 
secondary analysis of existing data, the study was constrained by the measures that were 
included in the assessment battery. Additional areas that would have been beneficial to 
explore such as details surrounding job/job performance, co-morbid disorders or premorbid 
functioning could not be assessed. Based on power analyses, it is likely that the study was 
underpowered to detect differences across certain measures; a larger sample size of 
Veterans would have been needed to assess for small or medium differences. Further, the 
settings for each sample were notably different. The non-Veteran sample were individuals 
actively engaged in a highly-specialized clinic focused on treating early psychosis. The 
Veteran sample were from a subject pool who were not receiving specialized care, and may 
not have been actively seeking treatment from the VA at the time of the study.  Finally, 
although beneficial for the direct comparisons between groups – both samples were from 
the same small geographical location, making generalization of results difficult. This study 
should be viewed as a pilot expedition, and should be used as a starting point for a larger 
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investigation to help determine whether these differences are consistent across Veteran 
populations nationwide.  
Conclusion 
Evidence from the current study suggests that Veterans with early psychosis are 
entering VAMC services, and would benefit from early, specialized treatment. As many 
similarities appear to exist between Veterans and non-Veterans with early psychosis, it may 
be possible to begin implementing evidence based interventions utilized in the general 
population within the VAMC Studying the services that Veterans with early psychosis do 
receive while at VAMCs would highlight areas to implement additional interventions. For 
example, identifying specific clinics that these Veterans utilize, may help identify the 
clinicians or service lines who may benefit most from additional training on identifying the 
signs and symptoms of early psychosis. Identifying the illness trajectory for Veterans – 
understanding when psychosis typically starts and how they come to the VAMC for 
services – may also offer insight as to where and when education and outreach should be 
added. It is clear that Veterans are experiencing early psychosis, but are not receiving the 
specialized care that is often made available to non-Veterans – thus understanding where 
these services would best fit within the Veteran healthcare system should be made a 
priority. 
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TABLES 
Table 1.  Sample Demographics 
  Total Sample Veteran Sample Non-Veteran Sample p 
  N % Mean (SD) N % Mean (SD) N % Mean (SD)  
Male  66 86.8  15 93.6  51 85.0  .36 
Race           <.001* 
     White 10 13.2  9 56.2  11 18.3   
     Minority 66 86.8  7 43.8  49 81.7   
Diagnosis           <.001* 
     Schizoaffective 17 22.4  10 62.5  7 11.7   
     Schizophrenia 55 72.4  5 31.3  50 83.3   
     Delusional Disorder 1 1.3  1 6.3  3 5.0   
     Brief Psychotic Disorder  3 3.9         
Age of illness onset  69  22.7 (4.6) 16  26.8 (4.9) 53  21.4 (3.7) <.001* 
DUP  69  318 days (511.0) 16  749 days (511.6) 53  188 days (437.8) <.001* 
CPZ Equivalents  76  315.5 (302.4) 16  158.3 (216.2) 60  357.4 (309.7) .02* 
Education           .001* 
    < HS Diploma 41 53.9  3 18.8  38 63.3   
    > HS Diploma 35 46.1  13 81.3  22 36.7   
Marital Status           <.001* 5
1
 
    
 
 
Table 1 Continued 
 
          
     Married/previously married 17 22.4  9 56.3  8 13.3   
     Single 59 77.6  7 43.8  52 86.7   
Notes: Categorical variables assessed using chi-square tests. Continuous variables assessed using independent samples t-tests. DUP=Duration of 
untreated psychosis. CPZ=Chlorpromazine equivalent medication. HS=High School.  
5
2
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Table 2. ANCOVA table for Veteran status and negative symptoms while controlling for 
race, diagnosis, marital status, age of onset, duration of untreated psychosis, education and 
CPZ equivalent at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Veteran Status .74 .39 .01 21.3 (6.1) 19.1 (6.5) 
Race .18 .67 .00   
Diagnosis 4.12 .05* .06   
Marital Status .60 .44 .01   
Age of Onset 1.06 .31 .02   
DUP .02 .89 .00   
Education .65 .42 .01   
CPZ Equivalent 1.11 .30 .02   
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. DV= 
Dependent variable. DUP=Duration of untreated psychosis. CPZ=Chlorpromazine 
equivalent medication. Means reported (M) are adjusted for covariates.  
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Table 3. ANCOVA for Veteran status and positive symptoms while controlling for race, 
diagnosis, marital status, age of onset, duration of untreated psychosis, education and CPZ 
equivalent at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Veteran Status 13.54 <.001* .18 22.4 (6.1) 14.5 (5.3) 
Race .49 .49 .01   
Diagnosis 1.69 .20 .03   
Marital Status 1.15 .30 .02   
Age of Onset .05 .82 .00   
DUP .65 .43 .01   
Education .03 .86 .00   
CPZ Equivalent 4.06 .05* .06   
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. 
DV=Dependent variable. DUP=Duration of untreated psychosis. CPZ=Chlorpromazine 
equivalent medications. Means reported (M) are adjusted for covariates. 
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Table 4. ANCOVA for Veteran status and depression while controlling for race, diagnosis, 
marital status, age of onset, duration of untreated psychosis, education and CPZ equivalent 
at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Veteran Status 1.08 .30 .02 11.5 (4.4) 9.9 (4.1) 
Race 1.22 .27 .02   
Diagnosis .32 .58 .01   
Marital Status 3.49 .07 .06   
Age of Onset .84 .36 .01   
DUP .78 .38 .01   
Education 1.05 .31 .02   
CPZ Equivalent 5.24 .03* .08   
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. 
DV=Dependent variable. DUP=Duration of untreated psychosis. CPZ=Chlorpromazine 
equivalent medications. Means reported (M) are adjusted for covariates. 
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Table 5. ANCOVA for Veteran status and social anxiety while controlling for race, 
diagnosis, marital status, age of onset, duration of untreated psychosis, education and CPZ 
equivalent at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Differences in Total Anxiety 
Veteran Status .03 .88 .00 96.2 (35.1) 92.9 (36.0) 
Race .34 .56 .01   
Diagnosis .22 .64 .01   
Marital Status .19 .67 .01   
Age of Onset .88 .36 .03   
DUP .02 .89 .00   
Education 3.51 .07 .11   
CPZ Equivalent .09 .77 .00   
Differences in Social Interaction 
Veteran Status .01 .94 .00 44.8 (16.9) 44.0 (17.6) 
Race .90 .35 .03   
Diagnosis .12 .74 .00   
Marital Status .26 .62 .01   
Age of Onset .85 .36 .03   
DUP .00 .98 .00   
Education 2.88 .10 .10   
CPZ Equivalent .04 .83 .00   
Differences in Public Performance 
Veteran Status .05 .83 .00 51.4 (19.3) 48.9 (19.0) 
Race .05 .82 .00   
Diagnosis .33 .57 .01   
Marital Status .12 .73 .00   
Age of Onset .83 .37 .03   
DUP .09 .77 .00   
Education 3.81 .06 .12   
CPZ Equivalent .14 .71 .00   
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Table 5 Continued:  
 
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. 
DV=Dependent variable. LSAS = Liebowitz Social Anxiety Scale. DUP=Duration of 
untreated psychosis. CPZ=Chlorpromazine equivalent medications. Means reported (M) 
are adjusted for covariates. 
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Table 6. ANCOVA for Veteran status and insight while controlling for race, diagnosis, 
marital status, age of onset, duration of untreated psychosis, education and CPZ equivalent 
at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Awareness of Illness 
Veteran Status 3.3 .07 .05 3.6 (1.3) 2.7 (1.3) 
Race 1.92 .003* .14   
Diagnosis 1.19 .28 .02   
Marital Status 1.69 .20 .03   
Age of Onset 2.25 .14 .04   
DUP .77 .38 .01   
Education .72 .40 .01   
CPZ Equivalent 2.32 .13 .04   
Need for Treatment 
Veteran Status 2.36 .13 .04 3.5 (1.3) 2.8 (1.2) 
Race 2.65 .11 .04   
Diagnosis 1.64 .21 .03   
Marital Status 4.31 .04* .07   
Age of Onset 1.39 .24 .02   
DUP .78 .38 .01   
Education .21 .65 .00   
CPZ Equivalent 2.19 .14 .04   
Consequence of Illness 
Veteran Status 3.24 .08 .05 4.2 (1.2) 3.4 (1.3) 
Race 1.12 .30 .02   
Diagnosis 1.78 .19 .03   
Marital Status 1.51 .22 .03   
Age of Onset 1.12 .29 .02   
DUP .10 .76 .00   
Education 1.01 .32 .02   
CPZ Equivalent 3.34 .07 .05   
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Table 6 Continued:  
 
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. 
DV=Dependent variable. DUP=Duration of untreated psychosis. CPZ=Chlorpromazine 
equivalent medication. Means reported (M) are adjusted for covariates. 
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Table 7. ANCOVA for Veteran status and social functioning while controlling for race, 
diagnosis, marital status, age of onset, duration of untreated psychosis, education and CPZ 
equivalent at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Social Withdrawal 
Veteran Status 1.99 .16 .03 93.2 (10.6) 100.6 (13.8) 
Race 1.94 .17 .03   
Diagnosis .84 .36 .01   
Marital Status 1.58 .21 .03   
Age of Onset .97 .33 .02   
DUP .76 .39 .01   
Education .07 .80 .00   
CPZ Equivalent 1.02 .32 .02   
Interpersonal Communication 
Veteran Status .00 .97 .00 117.5 (17.4) 117.3 (19.7) 
Race .23 .63 .00   
Diagnosis .18 .67 .00   
Marital Status .10 .53 .01   
Age of Onset .05 .82 .00   
DUP .76 .39 .01   
Education 1..69 .20 .03   
CPZ Equivalent .25 .62 .00   
Independent Performance 
Veteran Status .02 .90 .00 106.0 (9.0) 106.6 (12.7) 
Race 2.05 .16 .03   
Diagnosis 1.09 .30 .02   
Marital Status .61 .44 .01   
Age of Onset .63 .43 .01   
DUP 1.86 .18 .03   
Education 2.27 .14 .04   
CPZ Equivalent .10 .75 .00   
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Table 7 Continued 
Independent Competence 
Veteran Status .68 .41 .01 106.6 (10.5) 110.5 (12.7) 
Race .94 .34 .02   
Diagnosis 7.38 .01* .11   
Marital Status .07 .79 .00   
Age of Onset .11 .74 .00   
DUP .09 .77 .00   
Education 1.96 .17 .03   
CPZ Equivalent .15 .70 .00   
Recreation 
Veteran Status .16 .69 .00 112.7 (8.9) 110.5 (15.4) 
Race .70 .40 .01   
Diagnosis .94 .34 .02   
Marital Status .44 .51 .01   
Demographic F p 2 MVet Mnon-Vet 
Age of Onset 2.84 .10 .05   
DUP 7.52 .01* .11   
Education 4.11 .05* .07   
CPZ Equivalent .97 .33 .02   
Prosocial 
Veteran Status 2.87 .10 .05 110.1 (14.2) 119.2 (12.3) 
Race 1.27 .27 .02   
Diagnosis .23 .64 .00   
Marital Status .09 .76 .00   
Age of Onset .40 .53 .01   
DUP .00 .95 .00   
Education .23 .63 .00   
CPZ Equivalent .02 .89 .00   
Employment/Occupation 
Veteran Status 2.03 .16 .03 111.7 (14.9) 105.3 (10.1) 
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Table 7 Continued 
Race .86 .36 .02   
Diagnosis .23 .63 .00   
Marital Status 1.31 .26 .02   
Age of Onset .02 .88 .00   
DUP 4.17 .05* .07   
Education .00 .95 .00   
CPZ Equivalent 4.50 .04* .07   
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. 
DV=Dependent variable. DUP=Duration of untreated psychosis. CPZ=Chlorpromazine 
equivalent medication. Means reported (M) are adjusted for covariates. 
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Table 8. ANCOVA for Veteran status and role functioning while controlling for race, 
diagnosis, marital status, age of onset, duration of untreated psychosis, education and CPZ 
equivalent at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Instrumental Role 
Veteran Status 2.87 .10 .05 12.7 (8.4) 7.4 (8.2) 
Race 11.67 .001* .16   
Diagnosis .02 .90 .00   
Marital Status .34 .56 .01   
Age of Onset .11 .74 .00   
DUP 4.18 .05* .07   
Education .12 .73 .00   
CPZ Equivalent .03 .86 .00   
Common Objects and Activities 
Veteran Status 2.10 .16 .07 8.9 (1.3) 7.1 (2.6) 
Race .10 .75 .00   
Diagnosis .70 .41 .03   
Marital Status .07 .80 .00   
Age of Onset .29 .60 .01   
DUP .00 .96 .00   
Education 1.29 .27 .05   
CPZ Equivalent 1.22 .28 .04   
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. 
DV=Dependent variable. DUP=Duration of untreated psychosis. CPZ=Chlorpromazine 
equivalent medication. Means reported (M) are adjusted for covariates. 
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Table 9. ANCOVA for Veteran status and neurocognitive functioning while controlling for 
race, diagnosis, marital status, age of onset, duration of untreated psychosis, education and 
CPZ equivalent at time of assessment 
Demographic F p 2 MVet (SD) Mnon-Vet (SD) 
Total Score – Composite Total 
Veteran Status 4.86 .03* .15 35.9 (12.4) 21.4 (14.2) 
Race .00 .96 .00   
Diagnosis .02 .89 .00   
Marital Status .96 .34 .03   
Age of Onset 4.07 .05* .13   
DUP .91 .35 .03   
Education 11.62 <.01* .30   
CPZ Equivalent .02 .89 .00   
Word List – Verbal Memory 
Veteran Status .29 .59 .01 34.0 (10.9) 36.7 (10.1) 
Race .30 .59 .01   
Diagnosis .18 .68 .01   
Marital Status .26 .61 .01   
Age of Onset 1.45 .24 .05   
DUP .12 .74 .00   
Education 9.82 <.01* .27   
CPZ Equivalent 1.37 .25 .05   
Digit Sequence – Working Memory 
Veteran Status 10.38 <.01* .28 44.3 (11.9) 25.8 (12.4) 
Race .05 .83 .00   
Diagnosis .11 .74 .00   
Marital Status .58 .45 .02   
Age of Onset 6.75 .02* .20   
DUP 5.94 .02* .18   
Education 6.10 .02* .18   
CPZ Equivalent .13 .73 .01   
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Table 9 Continued 
Token Motor Task – Processing Speed 
Veteran Status 3.09 .09 .10 39.4 (8.9) 27.7 (12.8) 
Race .73 .40 .03   
Diagnosis .01 .94 .00   
Marital Status 1.95 .17 .07   
Age of Onset .00 .97 .00   
DUP .05 .83 .00   
Education .01 .92 .00   
CPZ Equivalent .29 .59 .01   
Verbal Fluency – Processing Speed 
Veteran Status 1.22 .28 .04 44.9 (9.3) 39.4 (11.8) 
Race 1.42 .24 .05   
Diagnosis 3.84 .06 .13   
Marital Status .05 .82 .00   
Age of Onset 7.62 .01* .22   
DUP .42 .52 .02   
Education 12.15 <.01* .31   
CPZ Equivalent .94 .34 .03   
Symbol Coding – Processing Speed 
Veteran Status .13 .72 .01 39.7 (9.6) 37.6 (10.7) 
Race .58 .46 .02   
Diagnosis 2.21 .15 .08   
Marital Status .01 .92 .00   
Age of Onset 1.29 .27 .05   
DUP .50 .50 .02   
Education 4.57 .04* .15   
CPZ Equivalent .36 .55 .01   
Tower of London - Reasoning 
Veteran Status 1.67 .21 .06 47.3 (17.1) 34.3 (19.8) 
Race 2.57 .12 .09   
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Table 9 Continued 
Diagnosis 3.30 .08 .11   
Marital Status 1.71 .20 .06   
Age of Onset .04 .84 .00   
DUP 1.03 .32 .04   
Education 3.51 .07 .12   
CPZ Equivalent .07 .80 .00   
Notes: The following categorical variables were dummy coded prior to entry into the 
ANCOVA analyses: Veteran status, race, diagnosis, marital status, education. 
DV=Dependent variable. DUP=Duration of untreated psychosis. CPZ=Chlorpromazine 
equivalent medication. Means reported (M) are adjusted for covariates. 
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Table 10. Bivariate Correlations of Demographic Variables  
 1 2 3 4 5 
1      
2 .50**     
3 .42** .57**    
4 .37** .55** .26*   
5 -.27* -.31** -.27* -.27*  
1= Veteran Status (Dummy coded) 
2= Age of Illness Onset 
3= Married Status (Dummy coded) 
4= Education Level (Dummy coded) 
5= CPZ Equivalents 
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Table 11. Logistic Regression showing association between Veteran Status and Marital 
Status controlling for Age of Onset 
   Marital Status   
Model Variable B B (SE) df p Exp(B) 
1 Age of Illness Onset .30 .10 1 <.01* 1.35 
2 Veteran Status -.99 .80 1 .22 .37 
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Table 12.  Logistic Regression showing association between Veteran Status and Education 
controlling for Age of Onset 
   Marital Status   
Model Variable B B (SE) df p Exp(B) 
1 Age of Illness Onset .33 .10 1 <.01* 1.38 
2 Veteran Status -.84 .82 1 .31 .43 
 
 
 
